Skip to content

The Effect of Postoperative Referred Pain in the Left Shoulder on Short-term Outcomes for Laparoscopic Gastrectomy

The Effect of Postoperative Referred Pain in the Left Shoulder on Short-term Outcomes for Laparoscopic Gastrectomy- A Prospective Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03482609
Enrollment
400
Registered
2018-03-29
Start date
2018-07-01
Completion date
2021-11-01
Last updated
2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach Neoplasms

Brief summary

The purpose of this study is to explore the effect of postoperative referred pain in the left shoulder on short-term outcomes for laparoscopic gastrectomy

Detailed description

A prospective cohort study will be performed to explore the effect of postoperative referred pain in the left shoulder on short-term outcomes for laparoscopic(including robot assisted laparoscopic surgery) gastrectomy .The evaluation parameters are overall postoperative morbidity rates,perioperative clinical efficacy and 3-year survival and recurrence rates.

Interventions

None listed

Sponsors

Fujian Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age from 18 to 75 years * Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy * cT1-4a, N0-3, M0 at preoperative evaluation according to the American Joint Committee on Cancer (AJCC) Cancer Staging Manual Seventh Edition * No distant metastasis is observed. And the spleen, pancreas or other adjacent organs are not involved by the tumor. * Performance status of 0 or 1 on Eastern Cooperative Oncology Group scale (ECOG) * American Society of Anesthesiology score (ASA) class I, II, or III * Written informed consent

Exclusion criteria

* patients whose previous history of chronic shoulder pain * Women during pregnancy or breast-feeding * Severe mental disorder * History of previous upper abdominal surgery (except laparoscopic cholecystectomy) * History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection * Enlarged or bulky regional lymph node envelop important vessels * History of other malignant disease within past five years * History of previous neoadjuvant chemotherapy or radiotherapy * History of unstable angina or myocardial infarction within past six months * History of cerebrovascular accident within past six months * History of continuous systematic administration of corticosteroids within one month * Requirement of simultaneous surgery for other disease * Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer * FEV1\<50% of predicted values * Difficulty of understanding V A S(Visual Analogues Score).

Design outcomes

Primary

MeasureTime frameDescription
The incidence of postoperative referred pain in the left shoulder within 1 month30 daysThe incidence of postoperative referred pain in the left shoulder within 1 month

Secondary

MeasureTime frameDescription
3-year disease overall survival rate36 months3-year disease overall survival rate
3-year disease free survival rate36 months3-year disease free survival rate
3-year recurrence pattern36 months3-year recurrence pattern
intraoperative morbidity rates1 dayThe intraoperative morbidity rates are defined as the rates of event observed within operation.
overall postoperative morbidity rates30 daysoverall postoperative morbidity rates
postoperative recovery course30 dayspostoperative recovery course
postoperative nutritional status and quality of life30 dayspostoperative nutritional status and quality of life
inflammatory and immune response7 daysinflammatory and immune response
overall postoperative serious morbidity rates30 daysoverall postoperative serious morbidity rates

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026